Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
16.09
+0.50 (+3.21%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ADMA Biologics Inc - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out
↗
February 14, 2026
This digital banking platform targets U.S. mass market consumers with mobile-first, fee-free services and strategic bank partnerships.
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth
↗
February 14, 2026
Solaris Energy Infrastructure delivers automation and logistics solutions to U.S. oil and gas operators using proprietary technologies.
Via
The Motley Fool
Topics
Energy
Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look
↗
February 14, 2026
Boot Barn Holdings operates over 500 stores nationwide, supplying western and workwear apparel to a diverse U.S. customer base.
Via
The Motley Fool
Topics
Regulatory Compliance
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
↗
August 01, 2025
Via
Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
↗
July 02, 2025
Via
Benzinga
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.
Via
The Motley Fool
Topics
Regulatory Compliance
ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate
↗
December 05, 2025
ADMA Biologics exemplifies GARP investing with strong revenue & earnings growth, high profitability, and a reasonable valuation relative to its biotech peers.
Via
Chartmill
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
↗
November 01, 2025
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
Via
The Motley Fool
How Is The Market Feeling About ADMA Biologics?
↗
June 04, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
ADMA Biologics Earnings Preview
↗
May 06, 2025
Via
Benzinga
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
↗
August 07, 2025
Via
Benzinga
Adma Biologics (ADMA) Q2 Revenue Up 14%
↗
August 06, 2025
Via
The Motley Fool
Topics
Economy
ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria
↗
June 13, 2025
ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential
↗
June 09, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup
↗
June 07, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock
↗
June 03, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech...
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing.
↗
May 09, 2025
Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...
Via
Chartmill
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
↗
May 08, 2025
Via
Benzinga
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
↗
May 08, 2025
The company makes immunoglobulin products using donated plasma.
Via
Investor's Business Daily
Topics
Earnings
3 Mid-Cap Medical Stocks Outperforming the Market
May 06, 2025
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.
Via
MarketBeat
Topics
Economy
Should you consider ADMA BIOLOGICS INC (NASDAQ:ADMA) for growth investing?
↗
May 05, 2025
A fundamental analysis of (NASDAQ:ADMA): Exploring growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).
Via
Chartmill
Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick?
↗
May 01, 2025
A fundamental and technical analysis of (NASDAQ:ADMA): Exploring ADMA BIOLOGICS INC (NASDAQ:ADMA)'s high growth characteristics.
Via
Chartmill
ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate
↗
May 01, 2025
ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate
Via
Chartmill
What's Going On With ADMA Stock Monday?
↗
April 28, 2025
ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
